Dominance of multidrug-resistant Denmark14-32 (ST230) clone among streptococcus pneumoniae serotype 19A isolates causing pneumococcal disease in Bulgaria from 1992 to 2013

Microbial Drug Resistance

Volumn 21, Issue 1, 2015, Pages 35-42

  Setchanova, Lena Petrova ^a   Alexandrova, Alexandra ^a   Dacheva, Daniela ^a   Mitov, Ivan ^a   Kaneva, Radka ^a   Mitev, Vanio ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; TETRACYCLINE; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BULGARIA; CHILD; CLONE; COLONY FORMING UNIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFANT; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; SCHOOL CHILD; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A ST230; VERY ELDERLY; CELL CLONE; CLASSIFICATION; DRUG EFFECTS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PNEUMOCOCCAL INFECTIONS;

STREPTOCOCCUS PNEUMONIAE;

ADULT; AGED; AGED, 80 AND OVER; BULGARIA; CHILD; CHILD, PRESCHOOL; CLONE CELLS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROGROUP; STREPTOCOCCUS PNEUMONIAE;

EID: 84922568185     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0076     Document Type: Review

References (28)

1. Aguiar, I.S., F.R. Pinto, S. Nunes, I. Serrano, J. Melo-Cristino, R. Sa-Leao, M. Ramirez, and H. de Lencastre. 2010. Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. J. Clin. Microbiol. 48:101-108.
2. Ardanuy, C., D. Rolo, A. Fenoll, D. Tarrago, L. Calatayud, and J. Linares. 2009. Emergence of a multidrugresistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J. Antimicrob. Chemother. 64:507-510.
3. Beall, B.W., R.E. Gertz, R.L. Hulkower, C.G. Whiney, M.R. Moore, and A.B. Brueggemann. 2011. Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J. Infect. Dis. 203:1360-1368.
4. Bogaert, D., R. De Groot, and P.W. Hermans. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4:144-154.
5. Carrico, J.A., C. Silva-Costa, J. Melo-Cristino, F.R. Pinto, H. de Lencastre, J.S. Almeida, and M. Ramirez. 2006. Illustration of a common framework for relating multiple typing methods by application to macrolideresistant Streptococcus pyogenes. J. Clin. Microbiol. 44: 2524-2532.
6. [CDC] Centers for Disease Control and Prevention. 2005. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb. Mortal. Wkly. Rep. 54: 893-897.
7. [CLSI] Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing, 23th ed. Approved standard M100-S23. CLSI, Wayne, PA.
8. Dagan, R., N. Givon-Lavi, E. Leibovitz, D. Greenberg, and N. Porat. 2009. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J. Infect. Dis. 199:776-785.
9. Enright, M.C., and B.G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
10. Feil, E.J., B.C. Li, D.M. Aanensen, W.P. Hanage, and B.G. Spratt. 2004. eBURST: Inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530.
11. Hanage, W.P., C.J. Bishop, G.M. Lee, M. Lipsitch, A. Stevenson, S.L. Rifas-Shiman, S.I. Pelton, S.S. Huang, and J.A. Finkelstein. 2011. Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine 29:8877-8881.
12. Hausdorff, W.P., B. Hoet, and L. Schuerman. 2010. Do pneumococcal conjugate vaccines provide any crossprotection against serotype 19A? BMC Pediatr. 10:4.
13. Mahioub-Messai, F., C. Doit, J.L. Koeck, T. Billard, B. Evrard, P. Bidet, C. Hubans, J. Raymond, C. Levy, R. Robert Cohen, and E. Bingen. 2009. Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after the introduction of 7-valent pneumococcal vaccination in French children. J. Clin. Microbiol. 47:837-840.
14. Marimon, J.M., M. Alonso, D. Rolo, C. Ardanuy, J. Lin ares, and E. Perez-Trallero. 2012. Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994-2009). Eur. J. Clin. Microbiol. Infect. Dis. 31:1009-1031.
15. Montanari, M.P., M. Mingoia, E. Giovanetti, and P.E. Varaldo. 2003. Phenotypes and genotypes of erythromycin-resistant pneumococci in Italy. J. Clin. Microbiol. 41:428-431.
16. Reinert, R., M.R. Jacobs, and S.L. Kaplan. 2010. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine 28:4249-4259.
17. Setchanova, L., A. Alexandrova, I. Mitov, D. Nashev, T. Kantardjiev, and The Group for Microbiological surveillance of pneumococci. 2012. Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in bulgaria before the introduction of pneumococcal conjugate vaccine. J. Chemother. 24:12-17.
18. Setchanova, L., T. Kostyanev, A. Alexandrova, I. Mitov, D. Nashev, and T. Kantardjiev. 2013. Microbiological characterization of Streptococcus pneumoniae and nontypeable Haemophilus influenzae isolates as primary causes of acute otitis media in Bulgarian children before the introduction of conjugate vaccines. Ann. Clin. Microbiol. Antimicrob. 12:6.
19. Setchanova, L., and A. Tomasz. 1999. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates from Bulgaria. J. Clin. Microbiol. 37:638-648.
20. Shin, J., J.Y. Baek, S.H. Kim, J.H. Song, and K.S. Ko. 2011. Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries. J. Antimicrob. Chemoter. 66:1001-1004.
21. Siira, L., J. Jalava, P. Tissari, M. Vaara, T. Kaijalainen, and A. Virolainen. 2012. Clonality behaind the increase of multidrug-resistance among non-invasive pneumococci in Southern Finland. Eur. J. Clin. Microbiol. Infect. Dis. 31:867-871.
22. Song, J.-H., R. Dagan, K.P. Klugman, and B. Fritzell. 2012. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 30:2728-2737.
23. Sorensen, U.B.S. 1993. Typing of pneumococci by using 12 pooled antisera. J. Clin. Microbiol. 31:2097-2100.
24. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
25. Tait-Kamradt, A., T. Davies, P.C. Appelbaum, F. Depardieu, P. Courvalin, J. Petitpas, L. Wondrack, A. Walker, M.R. Jacobs, and J. Sutcliffe. 2000. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother. 44:3395-3401.
26. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
27. Van der Linden, M., R.R. Reinert, W.V. Kern, and M. Imohl. 2012. Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children. BMC Infect. Dis. 13:70.
28. World Health Organization. 2012. Pneumococcal vaccines-WHO position paper. Wkly. Epidemiol. Rec. 87: 129-144.